Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 03/01/28
Due: 03/01/29
Phase: N/A
Priority: Normal
Start: 06/09/20
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 07/01/27
Due: 07/01/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) | NCT05488431 | Priscilla Hsue, MD | user2@example.com | None | 2023-03-01 | 2028-03-01 | 2029-03-01 | - | - | 2025-07-14 |
| Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients | NCT04421404 | Priscilla Hsue, MD | user2@example.com | None | 2020-06-09 | 2021-04-30 | 2022-04-30 | - | - | 2025-07-14 |
| Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk | NCT02272946 | Priscilla Hsue, MD | user2@example.com | None | 2015-09-30 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |
| Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial | NCT04939311 | Priscilla Hsue, MD | user2@example.com | None | 2022-07-01 | 2027-07-01 | 2028-07-01 | - | - | 2025-07-14 |